Joseph H Oved, Rebecca A Marsh, Aleksandra Petrovic
{"title":"先天性免疫缺陷的造血干细胞移植:何人及何时?","authors":"Joseph H Oved, Rebecca A Marsh, Aleksandra Petrovic","doi":"10.1111/bjh.20248","DOIUrl":null,"url":null,"abstract":"<p><p>Allogeneic haematopoietic cell transplant offers a potential cure for patients with inborn errors of immunity (IEI) but comes with its own set of complications and toxicities. In this nutshell article, we discuss factors that impact definitive therapy decisions in patients with IEI.</p>","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":" ","pages":"750-753"},"PeriodicalIF":3.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12337352/pdf/","citationCount":"0","resultStr":"{\"title\":\"Haematopoietic stem cell transplant for inborn errors of immunity-Who and when?\",\"authors\":\"Joseph H Oved, Rebecca A Marsh, Aleksandra Petrovic\",\"doi\":\"10.1111/bjh.20248\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Allogeneic haematopoietic cell transplant offers a potential cure for patients with inborn errors of immunity (IEI) but comes with its own set of complications and toxicities. In this nutshell article, we discuss factors that impact definitive therapy decisions in patients with IEI.</p>\",\"PeriodicalId\":135,\"journal\":{\"name\":\"British Journal of Haematology\",\"volume\":\" \",\"pages\":\"750-753\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12337352/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Haematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/bjh.20248\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/7 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Haematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/bjh.20248","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Haematopoietic stem cell transplant for inborn errors of immunity-Who and when?
Allogeneic haematopoietic cell transplant offers a potential cure for patients with inborn errors of immunity (IEI) but comes with its own set of complications and toxicities. In this nutshell article, we discuss factors that impact definitive therapy decisions in patients with IEI.
期刊介绍:
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.